Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)

פריטים דומים

• Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
  מאת: Tosato Giovanna, et al.
  יצא לאור: (2010-10-01)
• Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease
  מאת: Uldrick, Thomas S., et al.
  יצא לאור: (2014)
• Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)
  מאת: Yarchoan, R, et al.
  יצא לאור: (2009)
• KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease
  מאת: Polizzotto, Mark N, et al.
  יצא לאור: (2010)
• Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease
  מאת: Polizzotto, Mark N., et al.
  יצא לאור: (2013)